文章摘要

参考文献/References:

1 任成山, 王关嵩, 钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
2 Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China(the China Pulmonary Health[CPH] study): a national cross-sectional study[J]. Lancet, 2018, 391(10131): 1706-1717.
3 Fang L, Gao P, Bao H, et al. Chronic obstructive pulmonary disease in China: a nationwide prevalence study[J]. Lancet Respir Med, 2018, 6(6): 421-430.
4 Soriano JB, Lamprecht B. Chronic obstructive pulmonary disease: a worldwide problem[J]. Med Clin North Am, 2012, 96(4): 671-680.
5 Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey[J]. Am J Respir Crit CareMed, 2007, 176: 753-760.
6 Zhu YY, Chen WB. Science of Respiratory Disease. Beijing: People's Medical Punishing House, 2003: 974-1010.
7 Global Initiative for Chronic Obstructive Lung Disease(GOLD): Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease.(2018). http://www.goldcopd.org.
8 叶任高, 陆再英主编. 内科学[M]. 第六版, 北京:人民卫生出版, 2004, 137.
9 World Health Organization. Chronic obstructive pulmonary disease(COPD). 2011. Available from: http://www.who.int/respiratory/copd. Accessed September 25, 2014.
10 Koskela J, Kilpeläinen M, Kupiainen H, et al. Co-morbidities are the key nominators of the health related quality of life in mild and moderate COPD[J]. BMC Pulm Med, 2014, 14(1): 102.
11 Eisner MD, Blanc PD, Yelin EH, et al. COPD as a systemic disease: impact on physical functional limitations[J]. Am J Med, 2008, 121: 789-796.
12 Hillas G, Perlikos F, Tsiligianni I, et al. Managing comorbidities in COPD[J]. Int J Chron Obstruct Pulmon Dis, 2015, 10: 95-109.
13 Yin HL, Yin SQ, Lin QY, et al. Prevalence of comorbidities in chronic obstructive pulmonary disease patients: A meta-analysis[J]. Med, 2017, 96: 19(e6836).
14 Crisafulli E, Costi S, Luppi F, et al. Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation[J]. Thorax, 2008, 63(6): 487-492.
15 陈华萍, 胡明冬, 张君国, 等. 慢性阻塞性肺疾病合并症及其对预后的影响[J]. 解放军医学杂志, 2020, 45(8): 834-839.
16 Zhu YY, Chen WB. Science of respiratory disease. Beijing: People's Medical Punishing House, 2003: 97.
17 Aisanov ZR, Chuchalin AG, Kalmanova EN. Chronic obstructive pulmonary disease and cardiovascular comorbidity[J]. Kardiologiia, 2019, 59(8S): 24-36.
18 仇国俊. 低渗血症对慢性阻塞性肺疾病并发肺性脑病的影响[J]. 实用医院临床杂志, 2007, 4(6): 80-81.
19 Grigorakos L, Sakag ianni K. Outcome of acute heroin overdose requiring intensive care unit admission[J]. Opioid Manag, 2010, 6(3): 227-231.
20 王颖, 马铁英. 不同吸氧浓度对慢性阻塞性肺疾病病人的血气、智能和生活质量的影响[J]. 齐齐哈尔医学院学报, 2006, 27(6): 656-657.
21 陈盈. 慢性阻塞性肺疾病合并肺性脑病的治疗现状与进展[J]. 实用妇科内分泌杂志, 2017,(21): 6-8.
22 韩小彤. 无创双水平正压通气与呼吸兴奋剂联合治疗慢性阻塞性肺疾病合并肺性脑病的临床研究[J]. 现代预防医学, 2011, 38(8): 1580-1581,1583.
23 Roversi S, Roversi P. Coronary artery disease concomitant with chronic obstructive pulmonary disease[J]. Eur J Clin Invest, 2014, 44(1): 93-102.
24 LampleyD, VickiT. Anticipating and preventing delirium[J]. J OklaMed Assoc, 2002, 95: 71 -75.
25 林小平. 132例慢性阻塞性肺病急性期神志改变和病死率与pH的关系[J].中原医刊, 2002, 29(1): 12 -13.
26 林强. 肺性脑病54例救治体会[J]. 中华现代中西医学杂志, 2004, 16: 40.
27 叶俊红. 慢性肺源性心脏病并发肺性脑病相关分析[J]. 中国实用医药, 2007, 2(3): 15-16.
28 Li MH, Fan LC, Mao B, et al. Short-term Exposure to Ambient Fine Particulate Matter Increases Hospitalizations and Mortality in COPD: A Systematic Review and Meta-analysis[J]. Chest, 2016, 149(2): 447-458.

《中华肺部疾病杂志》[ISSN:1006-6977/CN:61-1281/TN]

文章信息/Info

参考文献/References:

备注/Memo

常用功能

导航/Navigate

工具/Tools

统计/Statistics